APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Stability Testing Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Drug Stability Testing Services Market Outlook and Growth Opportunities 2026

16 January 2026193 pages

Choose your research edition.

Industry ResearchDrug Stability Testing Services Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Stability Testing Services Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Drug Stability Testing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Stability Testing Services Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Stability Testing Services Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Drug Stability Testing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Drug Stability Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drug Stability Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Stability Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Drug Stability Testing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Drug Stability Testing Services market include SGS, Nelson Labs, Q Laboratories, Auriga Research, Intertek, Catalent, Pace Analytical, Charles River Laboratories and Impact Analytical, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Drug Stability Testing Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug Stability Testing Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug Stability Testing Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Drug Stability Testing Services market.

Drug Stability Testing Services Segment by Company

SGS

Nelson Labs

Q Laboratories

Auriga Research

Intertek

Catalent

Pace Analytical

Charles River Laboratories

Impact Analytical

Prolytix

Almac

Galbraith Laboratories, Inc.

Element

Drug Stability Testing Services Segment by Type

Early Development Stability Testing Services

Clinical Stability Testing Services

Predictive Stability Testing Services

In-use Stability Testing Services

Others

Drug Stability Testing Services Segment by Application

Pharmaceuticals

Biologics

Others

Drug Stability Testing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Drug Stability Testing Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Drug Stability Testing Services key companies, revenue, market share, and recent developments.

3. To split the Drug Stability Testing Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Drug Stability Testing Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Drug Stability Testing Services significant trends, drivers, influence factors in global and regions.

6. To analyze Drug Stability Testing Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Stability Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Stability Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Stability Testing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug Stability Testing Services industry.

Chapter 3: Detailed analysis of Drug Stability Testing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Drug Stability Testing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Drug Stability Testing Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Drug Stability Testing Services Industry Trends Table 2. Drug Stability Testing Services Industry Drivers Table 3. Drug Stability Testing Services Industry Opportunities and Challenges Table 4. Drug Stability Testing Services Industry Restraints Table 5. Global Drug Stability Testing Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Drug Stability Testing Services Revenue Share by Company (2021-2026) Table 7. Global Drug Stability Testing Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Drug Stability Testing Services Key Company Manufacturing Base & Headquarters Table 9. Global Drug Stability Testing Services Company, Product Type & Application Table 10. Global Drug Stability Testing Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Drug Stability Testing Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Early Development Stability Testing Services Table 15. Significant Companies of Clinical Stability Testing Services Table 16. Significant Companies of Predictive Stability Testing Services Table 17. Significant Companies of In-use Stability Testing Services Table 18. Significant Companies of Others Table 19. Global Drug Stability Testing Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Drug Stability Testing Services Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Drug Stability Testing Services Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Drug Stability Testing Services Sales Value Share by Type (2021-2026) Table 23. Global Drug Stability Testing Services Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Pharmaceuticals Table 25. Significant Companies of Biologics Table 26. Significant Companies of Others Table 27. Global Drug Stability Testing Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Drug Stability Testing Services Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Drug Stability Testing Services Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Drug Stability Testing Services Sales Value Share by Application (2021-2026) Table 31. Global Drug Stability Testing Services Sales Value Share by Application (2027-2032) Table 32. Global Drug Stability Testing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Drug Stability Testing Services Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Drug Stability Testing Services Sales Value Share by Region (2021-2026) Table 35. Global Drug Stability Testing Services Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Drug Stability Testing Services Sales Value Share by Region (2027-2032) Table 37. Global Drug Stability Testing Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Drug Stability Testing Services Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Drug Stability Testing Services Sales Value Market Share by Country (2021-2026) Table 40. Global Drug Stability Testing Services Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Drug Stability Testing Services Sales Value Market Share by Country (2027-2032) Table 42. SGS Company Information Table 43. SGS Business Overview Table 44. SGS Drug Stability Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. SGS Drug Stability Testing Services Product Portfolio Table 46. SGS Recent Development Table 47. Nelson Labs Company Information Table 48. Nelson Labs Business Overview Table 49. Nelson Labs Drug Stability Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Nelson Labs Drug Stability Testing Services Product Portfolio Table 51. Nelson Labs Recent Development Table 52. Q Laboratories Company Information Table 53. Q Laboratories Business Overview Table 54. Q Laboratories Drug Stability Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Q Laboratories Drug Stability Testing Services Product Portfolio Table 56. Q Laboratories Recent Development Table 57. Auriga Research Company Information Table 58. Auriga Research Business Overview Table 59. Auriga Research Drug Stability Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Auriga Research Drug Stability Testing Services Product Portfolio Table 61. Auriga Research Recent Development Table 62. Intertek Company Information Table 63. Intertek Business Overview Table 64. Intertek Drug Stability Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Intertek Drug Stability Testing Services Product Portfolio Table 66. Intertek Recent Development Table 67. Catalent Company Information Table 68. Catalent Business Overview Table 69. Catalent Drug Stability Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Catalent Drug Stability Testing Services Product Portfolio Table 71. Catalent Recent Development Table 72. Pace Analytical Company Information Table 73. Pace Analytical Business Overview Table 74. Pace Analytical Drug Stability Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Pace Analytical Drug Stability Testing Services Product Portfolio Table 76. Pace Analytical Recent Development Table 77. Charles River Laboratories Company Information Table 78. Charles River Laboratories Business Overview Table 79. Charles River Laboratories Drug Stability Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Charles River Laboratories Drug Stability Testing Services Product Portfolio Table 81. Charles River Laboratories Recent Development Table 82. Impact Analytical Company Information Table 83. Impact Analytical Business Overview Table 84. Impact Analytical Drug Stability Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Impact Analytical Drug Stability Testing Services Product Portfolio Table 86. Impact Analytical Recent Development Table 87. Prolytix Company Information Table 88. Prolytix Business Overview Table 89. Prolytix Drug Stability Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Prolytix Drug Stability Testing Services Product Portfolio Table 91. Prolytix Recent Development Table 92. Almac Company Information Table 93. Almac Business Overview Table 94. Almac Drug Stability Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Almac Drug Stability Testing Services Product Portfolio Table 96. Almac Recent Development Table 97. Galbraith Laboratories, Inc. Company Information Table 98. Galbraith Laboratories, Inc. Business Overview Table 99. Galbraith Laboratories, Inc. Drug Stability Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Galbraith Laboratories, Inc. Drug Stability Testing Services Product Portfolio Table 101. Galbraith Laboratories, Inc. Recent Development Table 102. Element Company Information Table 103. Element Business Overview Table 104. Element Drug Stability Testing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Element Drug Stability Testing Services Product Portfolio Table 106. Element Recent Development Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Drug Stability Testing Services Product Image Figure 2. Global Drug Stability Testing Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Stability Testing Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Drug Stability Testing Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Early Development Stability Testing Services Image Figure 8. Clinical Stability Testing Services Image Figure 9. Predictive Stability Testing Services Image Figure 10. In-use Stability Testing Services Image Figure 11. Others Image Figure 12. Global Drug Stability Testing Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Drug Stability Testing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Drug Stability Testing Services Sales Value Share by Type (2021-2032) Figure 15. Pharmaceuticals Image Figure 16. Biologics Image Figure 17. Others Image Figure 18. Global Drug Stability Testing Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Drug Stability Testing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Drug Stability Testing Services Sales Value Share by Application (2021-2032) Figure 21. Global Drug Stability Testing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Drug Stability Testing Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Drug Stability Testing Services Sales Value (2021-2032) & (US$ Million) Figure 24. North America Drug Stability Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Drug Stability Testing Services Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Drug Stability Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Drug Stability Testing Services Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Drug Stability Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Drug Stability Testing Services Sales Value (2021-2032) & (US$ Million) Figure 30. South America Drug Stability Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Drug Stability Testing Services Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Drug Stability Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Drug Stability Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Early Development Stability Testing Services
  • Clinical Stability Testing Services
  • Predictive Stability Testing Services
  • In-use Stability Testing Services
  • Others
Applications
  • Pharmaceuticals
  • Biologics
  • Others
Companies covered
  • SGS
  • Nelson Labs
  • Q Laboratories
  • Auriga Research
  • Intertek
  • Catalent
  • Pace Analytical
  • Charles River Laboratories
  • Impact Analytical
  • Prolytix
  • Almac
  • Galbraith Laboratories, Inc.
  • Element

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drug Stability Testing Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drug Stability Testing Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Drug Stability Testing Services Market Dynamics
  1. 2.1 Drug Stability Testing Services Industry Trends
  2. 2.2 Drug Stability Testing Services Industry Drivers
  3. 2.3 Drug Stability Testing Services Industry Opportunities and Challenges
  4. 2.4 Drug Stability Testing Services Industry Restraints
3 Drug Stability Testing Services Market by Company
  1. 3.1 Global Drug Stability Testing Services Company Revenue Ranking in 2025
  2. 3.2 Global Drug Stability Testing Services Revenue by Company (2021-2026)
  3. 3.3 Global Drug Stability Testing Services Company Ranking (2024-2026)
  4. 3.4 Global Drug Stability Testing Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Drug Stability Testing Services Company Product Type and Application
  6. 3.6 Global Drug Stability Testing Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Drug Stability Testing Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Drug Stability Testing Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Drug Stability Testing Services Market by Type
  1. 4.1 Drug Stability Testing Services Type Introduction
  2. 4.1.1 Early Development Stability Testing Services
  3. 4.1.2 Clinical Stability Testing Services
  4. 4.1.3 Predictive Stability Testing Services
  5. 4.1.4 In-use Stability Testing Services
  6. 4.1.5 Others
  7. 4.2 Global Drug Stability Testing Services Sales Value by Type
  8. 4.2.1 Global Drug Stability Testing Services Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Drug Stability Testing Services Sales Value by Type (2021-2032)
  10. 4.2.3 Global Drug Stability Testing Services Sales Value Share by Type (2021-2032)
5 Drug Stability Testing Services Market by Application
  1. 5.1 Drug Stability Testing Services Application Introduction
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Biologics
  4. 5.1.3 Others
  5. 5.2 Global Drug Stability Testing Services Sales Value by Application
  6. 5.2.1 Global Drug Stability Testing Services Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Drug Stability Testing Services Sales Value by Application (2021-2032)
  8. 5.2.3 Global Drug Stability Testing Services Sales Value Share by Application (2021-2032)
6 Drug Stability Testing Services Regional Value Analysis
  1. 6.1 Global Drug Stability Testing Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drug Stability Testing Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Drug Stability Testing Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Drug Stability Testing Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drug Stability Testing Services Sales Value (2021-2032)
  7. 6.3.2 North America Drug Stability Testing Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Drug Stability Testing Services Sales Value (2021-2032)
  10. 6.4.2 Europe Drug Stability Testing Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Drug Stability Testing Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Drug Stability Testing Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Drug Stability Testing Services Sales Value (2021-2032)
  16. 6.6.2 South America Drug Stability Testing Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Drug Stability Testing Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Drug Stability Testing Services Sales Value Share by Country, 2025 VS 2032
7 Drug Stability Testing Services Country-level Value Analysis
  1. 7.1 Global Drug Stability Testing Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Drug Stability Testing Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Drug Stability Testing Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Drug Stability Testing Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Drug Stability Testing Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Drug Stability Testing Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Drug Stability Testing Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 SGS
  2. 8.1.1 SGS Company Information
  3. 8.1.2 SGS Business Overview
  4. 8.1.3 SGS Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 SGS Drug Stability Testing Services Product Portfolio
  6. 8.1.5 SGS Recent Developments
  7. 8.2 Nelson Labs
  8. 8.2.1 Nelson Labs Company Information
  9. 8.2.2 Nelson Labs Business Overview
  10. 8.2.3 Nelson Labs Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Nelson Labs Drug Stability Testing Services Product Portfolio
  12. 8.2.5 Nelson Labs Recent Developments
  13. 8.3 Q Laboratories
  14. 8.3.1 Q Laboratories Company Information
  15. 8.3.2 Q Laboratories Business Overview
  16. 8.3.3 Q Laboratories Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Q Laboratories Drug Stability Testing Services Product Portfolio
  18. 8.3.5 Q Laboratories Recent Developments
  19. 8.4 Auriga Research
  20. 8.4.1 Auriga Research Company Information
  21. 8.4.2 Auriga Research Business Overview
  22. 8.4.3 Auriga Research Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Auriga Research Drug Stability Testing Services Product Portfolio
  24. 8.4.5 Auriga Research Recent Developments
  25. 8.5 Intertek
  26. 8.5.1 Intertek Company Information
  27. 8.5.2 Intertek Business Overview
  28. 8.5.3 Intertek Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Intertek Drug Stability Testing Services Product Portfolio
  30. 8.5.5 Intertek Recent Developments
  31. 8.6 Catalent
  32. 8.6.1 Catalent Company Information
  33. 8.6.2 Catalent Business Overview
  34. 8.6.3 Catalent Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Catalent Drug Stability Testing Services Product Portfolio
  36. 8.6.5 Catalent Recent Developments
  37. 8.7 Pace Analytical
  38. 8.7.1 Pace Analytical Company Information
  39. 8.7.2 Pace Analytical Business Overview
  40. 8.7.3 Pace Analytical Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pace Analytical Drug Stability Testing Services Product Portfolio
  42. 8.7.5 Pace Analytical Recent Developments
  43. 8.8 Charles River Laboratories
  44. 8.8.1 Charles River Laboratories Company Information
  45. 8.8.2 Charles River Laboratories Business Overview
  46. 8.8.3 Charles River Laboratories Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Charles River Laboratories Drug Stability Testing Services Product Portfolio
  48. 8.8.5 Charles River Laboratories Recent Developments
  49. 8.9 Impact Analytical
  50. 8.9.1 Impact Analytical Company Information
  51. 8.9.2 Impact Analytical Business Overview
  52. 8.9.3 Impact Analytical Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Impact Analytical Drug Stability Testing Services Product Portfolio
  54. 8.9.5 Impact Analytical Recent Developments
  55. 8.10 Prolytix
  56. 8.10.1 Prolytix Company Information
  57. 8.10.2 Prolytix Business Overview
  58. 8.10.3 Prolytix Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Prolytix Drug Stability Testing Services Product Portfolio
  60. 8.10.5 Prolytix Recent Developments
  61. 8.11 Almac
  62. 8.11.1 Almac Company Information
  63. 8.11.2 Almac Business Overview
  64. 8.11.3 Almac Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Almac Drug Stability Testing Services Product Portfolio
  66. 8.11.5 Almac Recent Developments
  67. 8.12 Galbraith Laboratories, Inc.
  68. 8.12.1 Galbraith Laboratories, Inc. Company Information
  69. 8.12.2 Galbraith Laboratories, Inc. Business Overview
  70. 8.12.3 Galbraith Laboratories, Inc. Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Galbraith Laboratories, Inc. Drug Stability Testing Services Product Portfolio
  72. 8.12.5 Galbraith Laboratories, Inc. Recent Developments
  73. 8.13 Element
  74. 8.13.1 Element Company Information
  75. 8.13.2 Element Business Overview
  76. 8.13.3 Element Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Element Drug Stability Testing Services Product Portfolio
  78. 8.13.5 Element Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst